Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis - Related Studies

Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis

This study has been completed.

Study NCT00005571. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Dermatomyositis

2	More general conditions related to this trial
		Connective Tissue Diseases
		Muscular Diseases
		Musculoskeletal Diseases
		Myositis
		Nervous System Diseases
		Neuromuscular Diseases
		Polymyositis
		Skin Diseases

3	Interventions listed in this trial
		h5G1.1-mAb

4	Sponsors listed in this trial
		National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)